systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»systhiper-146Research ArticleСТАТЬИARTICLESАртериальная гипотония у больных с вторичным гиперальдостеронизмом: синдромы Барттера и ГительманаЧихладзеН. М.noemail@neicon.ruОтдел системных гипертензий ФГУ РКНПК Росмедтехнологий, МоскваRussian Federation200823122022532426Copyright © Чихладзе Н.М., 20222022Чихладзе Н.М.Чихладзе Н.М.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/146ReferencesBartter FC, Pronove P, Gill JR et al. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokcalemic alkalosis. A new syndrome. Am J Med 1962; 33: 811-28.Bartter FC, Pronove P, Gill JR et al. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokcalemic alkalosis. A new syndrome. Am J Med 1962; 33: 811-28.Gitelman HJ, Graham JB, Welt LG. A new familial disorder Characterized by hypokcalemia and hypomagnesemia. Trans Assoc Am Physicians 1966; 79: 221-35.Gitelman HJ, Graham JB, Welt LG. A new familial disorder Characterized by hypokcalemia and hypomagnesemia. Trans Assoc Am Physicians 1966; 79: 221-35.Simon DB, Nelson-Williams C, Bia MJ et al. Gitleman's variant of Bartter's syndrome, inherited hypokcalemic alkalosis, in caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24-30.Simon DB, Nelson-Williams C, Bia MJ et al. Gitleman's variant of Bartter's syndrome, inherited hypokcalemic alkalosis, in caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24-30.Simon DB et al. Bartter's syndrome, hypokcalemic alkalosis with hypercaiciuria is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996; 13: 183-8.Simon DB et al. Bartter's syndrome, hypokcalemic alkalosis with hypercaiciuria is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996; 13: 183-8.Calo LA. Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes. Kidney Int 2006; 69: 963-6.Calo LA. Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes. Kidney Int 2006; 69: 963-6.Bhandari S, Turney JH. The molecular basis of hypocaliemic alkaloses: Bartter's and Gitelman's syndromes. Nephron 1998; 80: 373-9.Bhandari S, Turney JH. The molecular basis of hypocaliemic alkaloses: Bartter's and Gitelman's syndromes. Nephron 1998; 80: 373-9.Pachulski RT, Lopez F, Shazaf R. Gitelman's not-so-benign syndrome. New Eng J Med 2005; 335 (8): 850-1.Pachulski RT, Lopez F, Shazaf R. Gitelman's not-so-benign syndrome. New Eng J Med 2005; 335 (8): 850-1.Sartori M, Parotto E, Bonso E et al. Autonomic nervous system function in chronic hypotension associated with Bartter and Gitelman syndromes. Am J Kidney Dis 2007; 49 (2): 330-5.Sartori M, Parotto E, Bonso E et al. Autonomic nervous system function in chronic hypotension associated with Bartter and Gitelman syndromes. Am J Kidney Dis 2007; 49 (2): 330-5.Calo LA, Davis PA, Milani M et al. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Citelman's syndrome. Relationship to vascular reactivity. Clin Nephrol 1999; 51: 12-7.Calo LA, Davis PA, Milani M et al. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Citelman's syndrome. Relationship to vascular reactivity. Clin Nephrol 1999; 51: 12-7.
The authors declare that there are no conflicts of interest present.